2008 Clinical Scholar Research Award
Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr. Fuchs’s Research
Determining the Role of Nrf2 and Disrupted Iron Homeostasis in Innate Immune Response and Survival during Septic Shock in Critically Ill Adults.
Related Publications
The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Noel S, Zheng L, Navas-Acien A, Fuchs RJ.
Nuclear factor erythroid 2-related factor 2 (NRF2) has been shown to protect against experimental sepsis in mice and lipopolysaccharide (LPS)-induced inflammation in ex vivo white blood cells from healthy subjects by upregulating cellular antioxidant genes. The objective of this study…
Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
Thimmulappa RK, Fuchs RJ, Malhotra D, Scollick C, Traore K, Bream JH, Trush MA, Liby KT, Sporn MB, Kensler TW, Biswal S.
Sepsis is characterized by an inappropriate host immune-inflammatory response and sustained oxidative damage. Nrf2, a bZIP oxidant-responsive transcription factor, regulates a battery of cytoprotective genes including antioxidants and maintains cellular redox homeostasis. Mouse studies have demonstrated a critical role…
Read Dr. Fuchs’s recent publications and articles.
International Anesthesia Research Society
GuideStar/Candid